Garvan Institute of Medical Research

Garvan Institute of Medical Research Garvan Institute of Medical Research is a world leader, pioneering study into some of the most widespread diseases of today.
(204)

It aims to understand the genetic, molecular and cellular processes of health and disease as a basis for developing future cures.

Missed the deadline for the Sydney Marathon ballot? There is still an opportunity to . Be among just 25 runners support...
21/10/2025

Missed the deadline for the Sydney Marathon ballot?

There is still an opportunity to . Be among just 25 runners supporting pioneering medical research at a World Marathon Major.

Apply today: https://ow.ly/sJSU50XeJs8

In honour of Breast Cancer Awareness Month, the Garvan Institute hosted our annual public lecture to showcase the latest...
20/10/2025

In honour of Breast Cancer Awareness Month, the Garvan Institute hosted our annual public lecture to showcase the latest advances in breast cancer research. The event featured Garvan and international research leaders and oncologists, who shared their updates and advancements on new treatments, overcoming drug resistance, preventing metastasis, and promising clinical trials.

In an exciting moment of recognition, The Estée Lauder Companies presented the prestigious 2025 The Estée Lauder Companies Breast Cancer Research Award to Dr Hani Kim to support her project Dissecting APOBEC-Driven Immune Activation in Luminal Breast Cancer via Single-Cell Multiomics. Congratulations Hani!

We are incredibly grateful to The Estée Lauder Companies, for generously supporting Hani’s innovative and promising breast cancer research project. Your enduring support is helping to unlock answers that could save lives.

Meet Garvan immunologist Professor Stuart Tangye! 👋Professor Tangye is a founding member of CIRCA, a Garvan-based resear...
17/10/2025

Meet Garvan immunologist Professor Stuart Tangye! 👋

Professor Tangye is a founding member of CIRCA, a Garvan-based research collaboration that is transforming the way we tackle challenging immune diseases.

CIRCA is using genetic testing to uncover the gene disruptions that cause rare immune diseases. This crucial work is helping clinicians diagnose patients more quickly to guide effective, personalised treatments.

👉 Click here to find out how this research is making a difference: https://ow.ly/oqjb50Xbtj0

🏃‍♀️ Are you interested in becoming one of 25 gold charity runners for Garvan at the 2026 TCS Sydney Marathon?Join team ...
16/10/2025

🏃‍♀️ Are you interested in becoming one of 25 gold charity runners for Garvan at the 2026 TCS Sydney Marathon?

Join team Garvan and support life-changing medical research.

Click the link to submit your application to : https://ow.ly/3JMX50Xbufc

🔬 New insights into breast cancer treatment resistanceGarvan researchers have recently uncovered how a broken JNK pathwa...
14/10/2025

🔬 New insights into breast cancer treatment resistance

Garvan researchers have recently uncovered how a broken JNK pathway allows some ER+ breast cancers to resist standard therapies. Using CRISPR and tumour sample analyses, they found low JNK activity predicts poor response.

This discovery could lead to testing JNK levels before treatment, helping doctors personalise therapy and improve outcomes.

👉 Find out more: https://ow.ly/LAnw50Xaj7y

Huge congratulations to the following Garvan researchers who have received funding through the 2026 St Vincent’s Clinic ...
13/10/2025

Huge congratulations to the following Garvan researchers who have received funding through the 2026 St Vincent’s Clinic Research Foundation Grants.

· Dr Seyhan Yazar
· A/Prof David Croucher
· Dr Zoe Phan
· Dr Ashraf Zaman

Your research is having a transformative impact on health.

13/10/2025

At just a few weeks old, Stella developed an excruciating skin condition – the first in a relentless series of severe, worsening infections.

For 18 months, her family desperately searched for answers before finally being referred to the Clinical Immunogenomics Research Consortium Australasia (CIRCA) program, a global research collaboration based at Garvan. Through the work of CIRCA, Stella was able to receive a life-changing diagnosis and treatment.

👉 Click here to find out how CIRCA changed Stella’s life: https://ow.ly/JMjm50XaizG

At just a few weeks old, Stella developed a life-threatening condition that left doctors scratching their heads. Then ge...
10/10/2025

At just a few weeks old, Stella developed a life-threatening condition that left doctors scratching their heads.

Then genetic testing provided an answer that saved her life.

👉 Read her story: https://ow.ly/fh0O50X8Uai

We look forward to welcoming you to our annual breast cancer public lecture tomorrow. If you haven't signed up yet, it i...
09/10/2025

We look forward to welcoming you to our annual breast cancer public lecture tomorrow.

If you haven't signed up yet, it isn't too late!

🔗 Sign up here: https://ow.ly/oXLH50X8W0i

🗓️ Date: Friday, 10 October
🕒 Time: 2:00pm (AEDT)
📍 Location: Garvan auditorium or online

📊 How do we know if a cancer drug will work? It starts with choosing the right lab test.Newly published Garvan research ...
07/10/2025

📊 How do we know if a cancer drug will work? It starts with choosing the right lab test.

Newly published Garvan research compared different lab testing methods for PARP inhibitors – important drugs for people with cancers caused by BRCA mutations. We found that genetically matched cells (where scientists control specific gene changes) accurately predict patient responses, while standard cancer cell collections often show different patterns.

Why does this matter? It helps researchers worldwide choose more reliable testing methods when developing new therapies. When lab results align with patient outcomes, drug development becomes more efficient and promising treatments reach patients faster.

Small improvements in how science is done = big impacts for families 💜

Full study: https://pubmed.ncbi.nlm.nih.gov/40977519/

Did you know that the current rate of diagnosis for inborn errors of immunity (IEIs) is just 30%? These rare genetic dis...
05/10/2025

Did you know that the current rate of diagnosis for inborn errors of immunity (IEIs) is just 30%?

These rare genetic diseases arise from single gene disruptions that cause the immune system to malfunction.

Left undiagnosed IEIs lead to lifelong medical issues, with potentially fatal implications.

IEIs are hard to diagnose, but genetic testing changes lives. We aim to boost the diagnostic rate from 30% to 70%, allowing people to receive life-changing treatment faster.

This is why Garvan’s research in this area is vital.

Click this link to find out more: https://ow.ly/f6Uo50X5o1W

Address

384 Victoria Street
Darlinghurst, NSW
2010

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Garvan Institute of Medical Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Garvan Institute of Medical Research:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category